Since 2002 European and American pharmaceutical companies and Contract Research Organizations (CROs) have availed themselves of the services of MTZ Clinical Research (MTZ) a leading Polish company specializing in early phase clinical trials, bioequivalence and bioavailability studies.

Most studies are conducted at Company’s clinical research site which accommodates up to 30 subjects. It is also used as a specialized site for Phase III studies. MTZ also conducts single and multicentre trials (Phase II) at specialized clinics across Poland. Since August 2009 Company holds ISO 9001:2008, and from 2018 ISO 9001:2015 Certificate from DAS CERTIFICATION Ltd. accredited by UKAS.
MTZ conducts the following type of studies:
- Phase I/II healthy & patients, various indications
- Biosimilars healthy & patients
- Special populations
- Proof-of-Concept
- Bioequivalence and Bioavailability
- PK/PD, Food effect studies
- Therapeutic equivalence
- Tobacco risk evaluation & smoking-cessation studies.

MTZ has conducted over 260 research projects with over 6200 participating healthy subjects and patients who are recruited mainly from Company’s own registered database of volunteers.